-
公开(公告)号：KR100593254B1
公开(公告)日：2006-06-28
申请号：KR1020040033170
申请日：2004-05-11
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N1/20
Abstract: 본 발명은 엔테로코커스 에스피 58 (KACC 91099) 및 이의 용도에 관한 것으로서, 상기 균주는 내산성, 내담즙성 및 생체 안전성이 인정되고, 병원성 세균 억제활성을 가지며, 장내에서 독립된 균총(Niche)으로서의 활성과 이에 근거한 길항 작용을 통한 병원성 균총의 증식을 감소시켜 질병을 예방하는 효과가 있다.
-
公开(公告)号：KR100491174B1
公开(公告)日：2005-05-24
申请号：KR1020020075722
申请日：2002-11-30
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N15/861
Abstract: 본 발명은 일본 뇌염 바이러스 유전자 prME을 발현하는 돼지 아데노바이러스 3형(porcine adenovirus type 3: PAV3) 재조합 벡터(pPAV3E3-prME: 수탁번호 제KCTC 10376BP호), 및 그로부터 발현되는 재조합 돼지 아데노바이러스 3형(PAV3E3-prME) 및 일본 뇌염에 대한 백신으로서의 그의 용도에 관한 것이다.
-
公开(公告)号：KR1020040047485A
公开(公告)日：2004-06-05
申请号：KR1020020075722
申请日：2002-11-30
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N15/861
CPC classification number: C12N15/861 , C07K14/005 , C12N2770/24034
Abstract: PURPOSE: Recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME and use thereof are provided, thereby inducing immunity to Japanese encephalitis virus in human, and improving stability of the vaccine by using adenovirus. CONSTITUTION: A recombinant vector of porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME, pPAV3E3-prME(KCTC 10376BP), is prepared by removing E3 gene of porcine adenovirus type 3, and inserting the Japanese encephalitis virus gene prME under the control of E3 promoter, wherein the Japanese encephalitis virus gene prME has the nucleotide sequence set forth in SEQ ID NO: 1. A host cell transformed with the recombinant vector pPAV3E3-prME(KCTC 10376BP) is provided. The recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME(PAV3E3-prME) is obtained by culturing the transformed host cell. A vaccine for Japanese encephalitis virus comprises the recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME.
Abstract translation: 目的：提供3型表达日本脑炎病毒基因prME的重组猪腺病毒及其用途，从而诱导人体对日本脑炎病毒的免疫，并通过使用腺病毒提高疫苗的稳定性。 构成：通过除去3型猪腺病毒的E3基因，并将日本脑炎病毒基因prME置于E3的控制下，制备3型表达日本脑炎病毒基因prME，pPAV3E3-prME（KCTC 10376BP）的猪腺病毒重组载体 启动子，其中日本脑炎病毒基因prME具有SEQ ID NO：1所示的核苷酸序列。提供用重组载体pPAV3E3-prME（KCTC 10376BP）转化的宿主细胞。 通过培养转化的宿主细胞获得表达日本脑炎病毒基因prME（PAV3E3-prME）的重组猪腺病毒3型。 日本脑炎病毒疫苗包含3型表达日本脑炎病毒基因prME的重组猪腺病毒。
-
64.发明公开
公开(公告)号：KR1020040047483A
公开(公告)日：2004-06-05
申请号：KR1020020075720
申请日：2002-11-30
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N15/86
CPC classification number: A61K39/12 , A61K39/0005 , A61K2039/53 , A61K2039/552
Abstract: PURPOSE: A DNA vaccine using Japanese encephalitis virus and porcine immunoregulatory genes, and a method for using the same are provided, which DNA vaccine selectively uses strong cellular immunity and humoral immunity by change of genetic manipulation or administration pathway, minimizes side-effects by diluents in the administration area, inhibits pathogenicity recovering shown in live vaccine, and minimizes lowering of immunity when it is used with other disease vaccines. CONSTITUTION: The DNA vaccine using Japanese encephalitis virus and porcine immunoregulatory genes comprises a recombinant plasmid pSLIA-prME(KCTC 10378BP) containing Japanese encephalitis virus gene prME and a recombinant plasmid pSLIA-NS1(KCTC 10379BP) containing porcine immunoregulatory gene NS1, and further comprises a recombinant plasmid pSLIA-PIL-2(KCTC 10380) containing porcine interleukin-2 gene PIL-2, wherein the DNA vaccine is subcutaneously administered to pigs through the pig's tail. The method for preventing the infection of Japanese encephalitis virus comprises administering the recombinant plasmids pSLIIA-prME and pSLIA-NS1 into pigs, wherein the recombinant plasmid pSLIA-PIL-2 may be further administered into pigs.
Abstract translation: 目的：提供使用日本脑炎病毒和猪免疫调节基因的DNA疫苗及其使用方法，该DNA疫苗通过改变遗传操作或给药途径选择性地使用强的细胞免疫和体液免疫，从而最小化稀释剂的副作用 在管理区域，抑制活疫苗中显示的致病性恢复，并且当与其他疾病疫苗一起使用时，可以最大限度地降低免疫力。 构成：使用日本脑炎病毒和猪免疫调节基因的DNA疫苗包含含有日本脑炎病毒基因prME的重组质粒pSLIA-prME（KCTC 10378BP）和含有猪免疫调节基因NS1的重组质粒pSLIA-NS1（KCTC 10379BP），并且还包含 包含猪白细胞介素-2基因PIL-2的重组质粒pSLIA-PIL-2（KCTC10380），其中将DNA疫苗通过猪尾皮皮下施用于猪。 防止日本脑炎病毒感染的方法包括将重组质粒pSLIIA-prME和pSLIA-NS1投入猪，其中可以将重组质粒pSLIA-PIL-2进一步施用于猪。
-
65.发明授权유전자재조합 바큘로바이러스 및 이에 의한 재조합 돼지전염성위장염바이러스 스파이크 단백질을 이용한 돼지전염성위장염바이러스 항체 검출을 위한 효소면역 검사방법 有权重组杆状病毒和使用重组TGEV SPIKE蛋白的MACELISA检测特异性抗体对TGEV的检测
公开(公告)号：KR100267744B1
公开(公告)日：2000-11-01
申请号：KR1019980000446
申请日：1998-01-10
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: PURPOSE: Provided are a genetic recombinant baculovirus and a recombinant spike protein of transmissible gastroenteritis virus(TGEV) manufactured therefrom. And a monoclonal antibody capture enzyme linked immunosorbent assay for detecting the antibody of TGEV using the same protein is also provided, thereby the antibody of TGEV can be rapidly detected. CONSTITUTION: The recombinant spike protein of TGEV is produced by the steps of: isolating and identifying TGEV from pigs died of diarrhea; analyzing the nucleotide sequence of spike protein of TGEV; inserting the TGEV spike gene into the baculovirus gene to produce a recombinant baculovirus(KFCC-11015); infecting the recombinant baculovirus into SF9 cells to express TGEV spike protein. The antibody of TGEV is produced by inoculating the expressed recombinant TGEV spike protein into Guinea pigs. The monoclonal antibody capture enzyme linked immunosorbent assay using TGEV spike protein that is produced from the recombinant baculovirus(KFCC-11015) in Guinea pigs as an antigen is used in detecting the neutralizing antibody of TGEV.
Abstract translation: 目的：提供遗传重组杆状病毒和由其制备的传染性胃肠炎病毒（TGEV）的重组穗蛋白。 还提供了使用相同蛋白质检测TGEV抗体的单克隆抗体捕获酶联免疫吸附测定法，从而可以快速检测TGEV抗体。 构成：TGEV的重组穗蛋白是通过以下步骤制备的：从腹泻死亡的猪中分离和鉴定TGEV; 分析TGEV刺突蛋白的核苷酸序列; 将TGEV刺突基因插入杆状病毒基因以产生重组杆状病毒（KFCC-11015）; 将重组杆状病毒感染到SF9细胞中以表达TGEV穗蛋白。 通过将表达的重组TGEV穗蛋白接种到豚鼠中来产生TGEV抗体。 使用从作为抗原的豚鼠中的重组杆状病毒（KFCC-11015）产生的TGEV尖峰蛋白的单克隆抗体捕获酶联免疫吸附测定用于检测TGEV的中和抗体。
-
Patent Agency Ranking
公开(公告)号：KR1019990065235A
公开(公告)日：1999-08-05
申请号：KR1019980000447
申请日：1998-01-10
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N15/33
Abstract: 본 발명은 돼지 유행성설사바이러스의 스파이크(spike) 단백질이 중화항체를 유발하므로 이 스파이크 유전자를 곤충 바이러스인 베큘로바이러스에 삽입하여 발현된 스파이크 단백질(한국종균협회 균주기탁번호 KFCC-11014)을 이용하여 돼지유행성설사병 바이러스의 특이 중화항체검출방법에 관한 발명이다. 유전자재조합 방법으로 대량 생산된 돼지 유행성 설사바이러스 spike 단백질을 이용하여 간접 효소면역학적 측정법(IS-ELISA)으로 돼지 유행성설사바이러스 중화항체를 검출하는 방법을 제공하는 발명이다.
본 발명의 방법으로 보다 신속하고 정확하게 다수의 혈청을 사용하여 동시에 돼지 유행성설사바이러스 중화항체를 검사할 수 있다.-
67.发明授权
公开(公告)号：KR101462985B1
公开(公告)日：2014-11-18
申请号：KR1020120150976
申请日：2012-12-21
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: 본 발명은 제3형 조류파라믹소바이러스 (avian paramyxovirus-3, APMV-3)의 헤마글루티닌-뉴라미니다아제 (hemagglutinin-neuraminidase, HN) 단백질을 코딩하는 유전자를 포함하는 재조합 바이러스 발현 벡터, 상기 벡터에 의해 형질전환된 제3형 조류파라믹소바이러스의 헤마글루티닌-뉴라미니다아제 단백질을 발현하는 재조합 곤충 세포, 상기 재조합 곤충세포가 발현하는 제3형 조류파라믹소바이러스의 헤마글루티닌-뉴라미니다아제 재조합 항원 단백질을 포함하는 제3형 조류파라믹소바이러스 진단용 조성물, 진단 키트 및 이를 이용한 진단 방법에 관한 것이다. 본 발명에 따른 진단용 조성물은 살아있는 바이러스 취급에 따른 오염 가능성 없이 안전하고, 신속하게 대량의 샘플로부터 제3형 조류파라믹소바이러스의 감염 여부를 정확하게 진단할 수 있는 우수한 효과를 가지고 있다.
-
公开(公告)号：KR1020140086120A
公开(公告)日：2014-07-08
申请号：KR1020120156224
申请日：2012-12-28
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: The present invention relates to Mycoplasma synoviae Korean isolates which are main pathogenic bacteria which cause infectious synovitis and respiratory symptoms in chickens and, more specifically, to M.synoviae MS-09-AR vaccine (deposit number : KCTC12342BP) among M.synoviae isolates having high contagiousness and immunogenicity which are isolated from domestic chickens.
Abstract translation: 本发明涉及作为引起鸡的感染性滑膜炎和呼吸系统症状的主要病原体的分支支原体（Mycoplasma synoviae Korean），更具体地说，涉及具有以下特征的M.synoviae MS-09-AR疫苗（保藏号：KCTC12342BP） 高度的传染性和免疫原性，与家禽分离。
-
69.发明公开제2형 조류파라믹소바이러스의 헤마글루티닌―뉴라미니다아제의 재조합 항원 단백질 및 이용한 진단용 조성물 有权AVIAN PARAMYXOVIRUS-2的HEMAGGLUTININ-神经氨酸酶的重组抗原蛋白及其使用的诊断用组合物
公开(公告)号：KR1020140081332A
公开(公告)日：2014-07-01
申请号：KR1020120150960
申请日：2012-12-21
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: The present invention relates to a recombinant virus expression vector including a gene which encodes hemagglutinin-neuraminidase (HN) protein of avian paramyxovirus-2 (APMV-2); to recombinant insect cells transformed by the vector and expressing the HN protein of APMV-2; and to a diagnostic composition for APMV-2 including the recombinant antigenic HN protein of APMV-2 expressed by the recombinant insect cells, a diagnostic kit including the HN protein, and a diagnostic method using the HN protein. The diagnostic composition for APMV-2 according to the present invention is safe without the possibility of contamination caused by treatment of live viruses and has an excellent effect of quickly and accurately diagnosing whether there is infection with APMV-2 from a large number of samples.
Abstract translation: 本发明涉及包含编码禽副粘病毒-2（APMV-2）的血凝素 - 神经氨酸酶（HN）蛋白的基因的重组病毒表达载体; 通过载体转化并表达APMV-2的HN蛋白的重组昆虫细胞; 以及包含由重组昆虫细胞表达的APMV-2的重组抗原性HN蛋白质的APMV-2诊断组合物，包含HN蛋白质的诊断试剂盒和使用HN蛋白质的诊断方法。 根据本发明的APMV-2的诊断组合物是安全的，没有由病毒治疗引起的污染的可能性，并且具有快速且准确地诊断来自大量样品是否存在APMV-2感染的优异效果。
-
70.发明公开베큘러바이러스에 의하여 발현된 조류파라믹소바이러스-7 재조합 HN 단백질 및 이를 이용한 조류파라믹소바이러스-7의 진단 방법 有权由禽流感病毒表达的AVIAN PARAMYXOVIRUS型7型重组血红蛋白 - 神经酰胺糖苷酶蛋白及其使用的AVIAN PARAMYXOVIRUS型7的诊断方法
公开(公告)号：KR1020140081287A
公开(公告)日：2014-07-01
申请号：KR1020120150870
申请日：2012-12-21
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: The present invention relates to avian paramyxovirus (APMV)-7 recombinant hemagglutinin-neuraminidase (HN) protein expressed by baculoviruses, and a diagnostic method of APMV-7 using the same. The baculoviruses expressing APMV-7 HN protein according to the present invention, or insect cells transfected with the baculoviruses produce a high concentration of APMV-7 HN protein; easily enable the production of a large number of antigens even in a general laboratory allowing cell culture by using the APMV-7 HN protein; and enable the production of an antigen diagnostic reagent within a week by an insect cell culture method, thereby having an effect of shortening the production period of the antigen diagnostic reagent by at least one week. In addition, an APMV-7 HN protein antigen produced by the present invention has hemagglutination ability for erythrocytes of a chicken and thermal stability; has exhibited a specific HI reaction by APMV-7 immune serum; and also has an effect of exhibiting the same test result in comparison with a HI reaction test result from a conventional antigen (APMV-7 virus antigen). Therefore, a conventional APMV-7 virus antigen diagnostic reagent can be replaced with the APMV-7 HN protein antigen produced by the present invention even if infectious APMV-7 viruses are not secured.
Abstract translation: 本发明涉及由杆状病毒表达的禽副粘病毒（APMV）-7重组血凝素 - 神经氨酸酶（HN）蛋白，以及使用其的APMV-7的诊断方法。 表达本发明的APMV-7HH蛋白的杆状病毒或用杆状病毒转染的昆虫细胞产生高浓度的APMV-7HH蛋白; 即使在通常使用APMV-7HH蛋白的细胞培养的实验室中也容易产生大量抗原; 并且能够通过昆虫细胞培养法在一周内生产抗原诊断试剂，从而具有将抗原诊断试剂的生产周期缩短至少一周的效果。 此外，本发明生产的APMV-7HH蛋白抗原具有鸡的红细胞的血细胞凝集能力和热稳定性; 已经通过APMV-7免疫血清显示出特异的HI反应; 并且与常规抗原（APMV-7病毒抗原）的HI反应试验结果相比，具有显示相同试验结果的效果。 因此，即使不能确保感染性APMV-7病毒，也可以用本发明生产的APMV-7HH蛋白抗原代替传统的APMV-7病毒抗原诊断试剂。
-
-
-
-
-
-
-
-
-
Search Results
91
records
(took 0.024 seconds)
